Pharmaceuticals

Innovative Solutions In The Influenza Vaccine Enhanced Growth Is Playing A Role In Shaping The Albumin Excipient Market

April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Albumin Excipient Market Be By 2030 Compared To Its 2026 Market Size?

The albumin excipient market has shown strong expansion in recent years. It is projected to increase from $5.15 billion in 2025 to $5.47 billion in 2026, growing at a compound annual growth rate (CAGR) of 6.2%. The growth observed historically is attributable to the rising demand for biologics, increasing research in protein-based excipients, growth in pharmaceutical manufacturing, adoption of recombinant albumin, and the development of stabilized formulations.

The market for albumin excipients is projected to experience substantial expansion over the upcoming years. This market is predicted to reach $7.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. Several factors are expected to drive this growth during the projection period, including the expanding biopharmaceutical industry, innovations in protein excipient technology, a greater incidence of chronic illnesses, an increase in contract manufacturing activities, and more regulatory clearances for new drug formulations. Key trends anticipated within the forecast timeframe encompass breakthroughs in protein stabilization, improvements in excipient formulations, more effective drug delivery mechanisms, adherence to regulatory standards and Good Manufacturing Practices (GMP), and improved supply chain efficiency.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10672&type=smp

What Key Factors Are Shaping The Albumin Excipient Market Landscape?

The increasing occurrence of chronic diseases is an anticipated factor driving the expansion of the albumin excipient market. Defined as an ailment persisting for at least three months, chronic diseases are conditions that may worsen over time. Albumin serves as a blood volumizer and represents the most plentiful protein found circulating within plasma. Its role extends to being a versatile protein carrier, facilitating drug targeting and enhancing the pharmacokinetic characteristics of peptide or protein-based medications used in managing numerous conditions like cancer and diabetes. As an illustration, the World Health Organization, a Switzerland-based United Nations agency, stated in February 2024 a projection of more than 35 million new cancer cases by 2050, signifying a 77% surge from the approximately 20 million cases recorded in 2022. Consequently, the expanding incidence of chronic diseases is fueling the development of the albumin excipient market.

Which Segment Categories Are Included In The Albumin Excipient Market Segment Analysis?

The albumin excipient market covered in this report is segmented –

1) By Product: Human Serum Albumin, Recombinant Albumin

2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users

3) By Application Type: Injectable Formulations, Vaccine Formulations, Cell Culture Or Bioprocessing, Diagnostic Formulations

Subsegments:

1) By Human Serum Albumin: 5% Human Serum Albumin, 20% Human Serum Albumin

2) By Recombinant Albumin: Recombinant Human Serum Albumin, Recombinant Bovine Serum Albumin

What Trends Are Shaping The Future Of The Albumin Excipient Market?

Leading companies in the albumin excipient market are employing a strategic partnership strategy to support vital biotechnology and pharmaceutical industries. Strategic collaborations involve organizations harnessing each other’s strengths and resources to achieve mutual advantages and successful results. For example, in October 2023, ARTES Biotechnology GmbH, a Germany-based biotechnology company, partnered with Basic Pharma, a Netherlands-based pharmaceutical company, to further recombinant protein production. This collaboration aims to enhance pharmaceutical recombinant protein production by optimizing the supply chain and reducing the time-to-market for new products.

Who Are The Active Companies Shaping The Albumin Excipient Market?

Major companies operating in the albumin excipient market are Albumin Therapeutics LLC, Biotest AG, CSL Behring, Grifols S.A., InVitria Inc., Octapharma AG, Kedrion Biopharma, LFB USA Inc., Baxter International Inc., Merck KGaA, Albumedix A/S, Bio Products Laboratory Ltd., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc., Shire Plc, Biopharma, Hualan Biological Engineering Inc., Shanghai RAAS Blood Products Co. Ltd.

Get The Full Albumin Excipient Market Report:

https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report

Which Geographic Region Dominates The Albumin Excipient Market?

North America was the largest region in the Albumin Excipient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Albumin Excipient Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report

Browse Through More Reports Similar to the Global Albumin Excipient Market 2026, By The Business Research Company

Albumin Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report

Albumin Market Report 2026

https://www.thebusinessresearchcompany.com/report/albumin-global-market-report

Alcohol Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/alcohol-excipients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795